Bo Cen to Cell Line, Tumor
This is a "connection" page, showing publications Bo Cen has written about Cell Line, Tumor.
Connection Strength
0.526
-
Bcl-2 and Bcl-xL mediate resistance to receptor tyrosine kinase-targeted therapy in lung and gastric cancer. Anticancer Drugs. 2017 11; 28(10):1141-1149.
Score: 0.105
-
Activation of Pim Kinases Is Sufficient to Promote Resistance to MET Small-Molecule Inhibitors. Cancer Res. 2015 Dec 15; 75(24):5318-28.
Score: 0.092
-
The Pim-1 protein kinase is an important regulator of MET receptor tyrosine kinase levels and signaling. Mol Cell Biol. 2014 Jul; 34(13):2517-32.
Score: 0.082
-
Elevation of receptor tyrosine kinases by small molecule AKT inhibitors in prostate cancer is mediated by Pim-1. Cancer Res. 2013 Jun 01; 73(11):3402-11.
Score: 0.077
-
A bivalent cyclic RGD-siRNA conjugate enhances the antitumor effect of apatinib via co-inhibiting VEGFR2 in non-small cell lung cancer xenografts. Drug Deliv. 2021 Dec; 28(1):1432-1442.
Score: 0.035
-
Melatonin reverses nasopharyngeal carcinoma cisplatin chemoresistance by inhibiting the Wnt/?-catenin signaling pathway. Aging (Albany NY). 2020 03 23; 12(6):5423-5438.
Score: 0.031
-
LncRNA-135528 inhibits tumor progression by up-regulating CXCL10 through the JAK/STAT pathway. Apoptosis. 2018 12; 23(11-12):651-666.
Score: 0.028
-
Protective effect of Gelofusine against cRGD-siRNA-induced nephrotoxicity in mice. Ren Fail. 2018 Nov; 40(1):187-195.
Score: 0.028
-
A tumor-targeting cRGD-EGFR siRNA conjugate and its anti-tumor effect on glioblastoma in vitro and in vivo. Drug Deliv. 2017 Nov; 24(1):471-481.
Score: 0.026
-
Regulation of prostate stromal fibroblasts by the PIM1 protein kinase. Cell Signal. 2015 Jan; 27(1):135-46.
Score: 0.021